Breakthrough T1D is in Animal Crossing™ New Horizons!
When Insulet, the makers of Omnipod®, asked us to team up on bringing diabetes representation to Animal Crossing™, we couldn’t say no!
Tandem Diabetes Makes Managing T1D More Convenient
Tandem announced the FDA clearance of bolus insulin dosing from their t:connect® mobile app. Soon, individuals with the Tandem t:slim X2™ pump will be able to bolus remotely from either their iOS or Android smartphone.
A Mother on a Mission to Cure T1D
“What drives us as parents is the love we have for our children and the passionate hope that there is a cure out there and it’s within reach.” – Lee Ducat
FDA Approval of Senseonics Eversense® CGM for Use for Up to 6 Months
FDA approves Senseonics Eversense® E3, the first long-term implantable CGM system, and the E3 includes technology that extends the use for up to 6 months.
100 Years, 100 Breakthrough T1D Scientists: The BB Rat—An Animal Model of Type 1 Diabetes
In 1974, a colony of non-diabetic BB rats develops diabetes. Examination of their pancreases revealed that they had no beta cells.
Employee Spotlight: Meet Tricia Martin
This Black History Month, the Black at Breakthrough T1D Employee Resource Group, in collaboration with the Diversity and Inclusion Task Force and the Greater New York City Chapter, would like to acknowledge our colleague Tricia Martin whose more than 20 years of service to Breakthrough T1D exemplifies Black Excellence and a commitment to diversity and […]
The First Gene-Edited Cell Replacement Therapy Takes a Step Forward
The first person has received ViaCyte and CRISPR's cell replacement therapy.
FDA Authorizes a Fourth Artificial Pancreas System
The FDA authorized the Insulet Omnipod 5, the world’s first tubeless, wearable system for people 6 and older, using an algorithm that began by Breakthrough T1D funding.
Interview with our New Community Screening and Clinical Trial Education Director
Breakthrough T1D has a new community screening and clinical trials education director. She's been a volunteer and now staff since her daughter was diagnosed in 2002.
New Study Shows Kids 1+ Benefit from Artificial Pancreas Technology
A new paper published in the New England Journal of Medicine shows hybrid closed loop systems help children as young as 1 year old achieve better glycemic control.
